CTSH and Alzheimer disease: There was a trend toward reduction of median CTSH levels in the AD RNA sequencing analysis (see Fig E5, D)21; however, consistent with the lack of change in FLG mRNA levels, there was no correlation between filaggrin levels and CTSH in patients with AD (see Fig E5, E).